Phoenix Biotech Acquisition Corp
NASDAQ:CERO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Phoenix Biotech Acquisition Corp
Net Change in Cash
Phoenix Biotech Acquisition Corp
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Phoenix Biotech Acquisition Corp
NASDAQ:CERO
|
Net Change in Cash
$811.7k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Net Change in Cash
-$418.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Net Change in Cash
$691.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Net Change in Cash
$549.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
1%
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Net Change in Cash
$64m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Net Change in Cash
$2.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Phoenix Biotech Acquisition Corp
Glance View
Phoenix Biotech Acquisition Corp. operates as a blank check company. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2021-10-06. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The company intends to focus its search on the healthcare or healthcare related industries in the United States and Europe. The firm has not commenced any operations nor generated any revenues.
See Also
What is Phoenix Biotech Acquisition Corp's Net Change in Cash?
Net Change in Cash
811.7k
USD
Based on the financial report for Dec 31, 2024, Phoenix Biotech Acquisition Corp's Net Change in Cash amounts to 811.7k USD.
What is Phoenix Biotech Acquisition Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-10%
The average annual Net Change in Cash growth rates for Phoenix Biotech Acquisition Corp have been -10% over the past three years .
